Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Truitt Kenneth — Aquestive Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Truitt Kenneth

Truitt Kenneth

Chief Medical Officer at Aquestive Therapeutics, Inc. · on record since Sep 8, 2022

Insider trading activity of Truitt Kenneth

Transactions on record: 1; since Sep 8, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Sep 8, 2022

Figures computed from official regulatory filings — methodology.

Companies where Truitt Kenneth has traded

Aquestive Therapeutics, Inc.1 tx · Sep 8, 2022

Track record of Truitt Kenneth

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Truitt Kenneth

Co-insiders of Truitt Kenneth

Barber DanielAquestive Therapeutics, Inc.
Boyd Peter E.Aquestive Therapeutics, Inc.
BRAENDER LORI JAquestive Therapeutics, Inc.
Bratton Capital Inc.Aquestive Therapeutics, Inc.
Bratton Capital Management, L.P.Aquestive Therapeutics, Inc.
BRATTON DOUGLAS KAquestive Therapeutics, Inc.
BROWN GREGORY BAquestive Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Cioffi MelinaAquestive Therapeutics, Inc.

Cochran JohnAquestive Therapeutics, Inc.

COSTA SANTO JAquestive Therapeutics, Inc.

Davis Matthew W.Aquestive Therapeutics, Inc.

Greenhawt Matthew J.Aquestive Therapeutics, Inc.

Jenkins Abigail L.Aquestive Therapeutics, Inc.

Jung CassieAquestive Therapeutics, Inc.

Kendall Keith JAquestive Therapeutics, Inc.

Korczynski SherryAquestive Therapeutics, Inc.

Kraus Carl NAquestive Therapeutics, Inc.

Krop JulieAquestive Therapeutics, Inc.

Lurker NancyAquestive Therapeutics, Inc.

Marshall Ken W.Aquestive Therapeutics, Inc.

Maxwell John T.Aquestive Therapeutics, Inc.

Monoline Partners, L.P.Aquestive Therapeutics, Inc.

Monoline RX III, L.P.Aquestive Therapeutics, Inc.

MonoLine RX II, L.P.Aquestive Therapeutics, Inc.

MonoLine RX, L.P.Aquestive Therapeutics, Inc.

MonoSol Rx Genpar, L.P.Aquestive Therapeutics, Inc.

MORRIS TIMOTHY EAquestive Therapeutics, Inc.

MRX Partners, LLCAquestive Therapeutics, Inc.

Schobel Alexander MarkAquestive Therapeutics, Inc.

Scibetta James SAquestive Therapeutics, Inc.

Slatko Gary HAquestive Therapeutics, Inc.

Taglietti MarcoAquestive Therapeutics, Inc.

TOTH A ERNEST JRAquestive Therapeutics, Inc.

Wargacki StephenAquestive Therapeutics, Inc.

Wood TheresaAquestive Therapeutics, Inc.

Zalewski Thomas A.Aquestive Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Aquestive Therapeutics, Inc.	Sep 8, 2022	AwardD	100,000	0.00 USD	$0	SEC